lomustine and plx4032
lomustine has been researched along with plx4032 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hernberg, M; Kohtamäki, L; Koivunen, J; Mäkelä, S; Mattila, KE; Ramadan, S; Skyttä, T; Tiainen, L; Tyynelä-Korhonen, K; Vihinen, P; Vuoristo, MS | 1 |
Other Studies
1 other study(ies) available for lomustine and plx4032
| Article | Year |
|---|---|
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Female; Follow-Up Studies; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Prognosis; Survival Rate; Temozolomide; Vemurafenib; Vincristine | 2020 |